In transgenic research, selection markers have greatly facilitated the generation of transgenic 19 animals. A prerequisite for a suitable selection marker to be used along with a test gene of 20 interest is that the marker should not affect the phenotype of interest in transformed animals.
INTRODUCTION
Efficient transgenic techniques are used in various model systems to detect gene expression 33 and assess genetic function. In the nematode Caenorhabditis elegans, for example, gene 34 expression can be monitored using transgenic worms generated by a simple, gonadal 35 microinjection of a plasmid that drives GFP expression under the control of a promoter for a 36 gene of interest [1] . During the course of the DNA transformation procedure, one easy way to 37 select transformed animals is by using easily-detected co-injection markers. In C. elegans, 38 several co-injection markers are commonly used, which include visible fluorescent markers 39 (e.g. ttx-3p::GFP, myo-2p::mCherry) [2, 3] and rescuing markers that restore lethal or non-40 lethal phenotypes (e.g. pha -1, unc-119, dpy-5) [4] [5] [6] . One type of dominant selectable marker, 41 rol-6(su1006), is widely used, because it shows a dominant roller phenotype that is easily 42 observed and can be used in a wild type background [7, 8] .
43
A prerequisite for the use of co-injection markers is that the phenotype induced by the 44 co-injection marker must not interfere with expression or scoring of the gene being tested. In 45 this study, we report that the widely-used rol-6 marker unexpectedly activates the test gene in 46 a male interneuron called CP09 in C. elegans. This unwanted expression could potentially 47 result in misidentification of cell types in a gene expression study as well as affect the results 48 of functional studies that utilize rol-6 as a co-injection marker. 
RESULTS AND DISCUSSION

51
During the course of experiments to determine the tissue-specific expression pattern of 10 52 putative synaptic genes in C. elegans, we generated transgenic worms with promoter::GFP test 53 genes using rol-6(su1006) as a co-injection marker. We noticed that in eight out of 10 54 transgenic lines, GFP was expressed in the CP09 neuron among other diverse neurons [9] .
55
CP09 is a male-specific interneuron located in the pre-anal ganglion of the male tail that forms 56 chemical and electrical synapses with many other male-specific or sex-shared neurons (Fig 1) . expression, four of the transgenes were expressed in most or many neurons (i.e. many CP 62 neurons), but the other four were expressed exclusively in CP09 among the 10 CP neurons.
63
Therefore, we suspected that the CP09 expression may be an expression artifact.
64
It is widely known that GFP reporters driven by diverse promoters often show artificial 65 fluorescence in posterior gut cells, in several muscle cells, and even in one neuron called PVT 66 [14, 15]. One potential cause of these artifacts was suggested to be an effect of the unc-54 3′ 67 UTR, which is attached to the GFP coding sequence in most C. elegans vectors [15] . To test 68 whether the unc-54 3′ UTR can also cause expression in CP09, we replaced the unc-54 3′ UTR 69 with the let-858 3′ UTR in a promoter::GFP fusion for one of the test genes that showed 70 exclusive expression in CP09 among the 10 CP neurons (T19A6.4 gene). When transgenic 71 animals were generated by microinjection of the T19A6.4p::GFP::let-858 3' UTR fusion along 72 with the rol-6 co-injection marker, they still showed CP09 expression, suggesting that at least 5 73 for this gene factors other than the unc-54 3′ UTR are likely involved in the generation of the 74 CP09 signal (data not shown).
75
The second possibility was that the rol-6 co-injection marker used in the 76 microinjection procedure caused the expression in CP09. To test this idea, we injected an empty 77 GFP vector (pPD95.75), which contains no promoter for the GFP coding sequence, together 78 with the rol-6 co-injection marker (pRF4). The resulting transgenic animal showed a robust 79 GFP expression in CP09 (Fig 2A) . However, when the empty GFP vector was injected with 80 another co-injection marker ttx-3p::GFP (expressed in AIY neuron in the head), the CP09 81 signal was not observed ( Fig 2B) . Thus, the rol-6 co-injection marker itself can promote 82 transcription in the CP09 neuron. ampicilin resistance gene and origin of replication. We also found a 40 bp homology shared 89 between the pRF4 plasmid and GFP constructs generated by promoter::GFP fusion PCR, which 90 constitutes the multiple cloning site of the vectors (minimum homology with GFP constructs) 91 ( Fig 3A) . The full sequence information of pRF4 is available in S1 Text. (Although pRF4 has 92 been used widely in the C. elegans research community, the accurate pRF4 sequence, to our 93 knowledge, is not yet available in public.) 94 To find a region responsible for CP09 expression, we divided the pRF4 plasmid into 95 two fragments, namely "rol-6" and "vector" fragments, and cloned these into the empty GFP 96 vector pPD95.75. When the rol-6 fragment::GFP was injected, the resulting transgenic animal 6 97 showed a robust GFP expression in CP09 ( Fig 3B) . However, we could not observe any GFP 98 expression in CP09 when the vector fragment::GFP was used for injection ( Fig 3B) . Therefore, 99 it is likely that when a GFP construct is injected together with the rol-6 co-injection marker 100 pRF4, the rol-6 fragment fused to GFP by homologous recombination generates unwanted 101 transcription and GFP expression in CP09 ( Fig 3C) .
102
Our results raise an obvious problem in using the rol-6 co-injection marker for gene Worms were prepared and imaged as described previously [21] . Briefly, 1-day-old males were 156 mounted on 5% agar pads on glass slides using 10~50 mM sodium azide. Worms were 157 observed with fluorescence microscopy (Zeiss Axio Imager.Z2) or confocal microscopy 158 (Nikon Eclipse Ti). Images were processed using AxioVision (Zeiss) or NIS-Elements (Nikon).
159
Figures were prepared using ImageJ software. 
